Treace Medical Concepts, Inc.(TMCI)

$4.46▲0.01 (22.47%)

Chart

Treace Medical Concepts, Inc.(TMCI)

NASDAQ

$4.46▲0.01 (22.47%)

Chart Studio

TMCI(TMCI)

TMCI

Overview Notebook Intelligence Chart History Fundmntls TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Q3 2026 EPS Estimate

$-0.30

Aug 6, 2026 · Reports before open

Revenue Estimate

$44M

Analyst Sentiment

Wall St. Consensus

Hold

9 analysts·Limited coverage

Score

2 Buy (22%)6 Hold (67%)1 Sell (11%)

Rating Breakdown

Strong Buy

00%

Buy

222%

Hold

667%

Sell

111%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$3.00

-32.7%

Consensus

$3.00

-32.7%

Bull

$3.00

-32.7%

12-Month Target Range9 analysts

$3.00$3.00$3.00

Current $4.46Consensus

Current Price

$4.46

Above Consensus

$1.46

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+7.55%

EPS—

FY2028

Rev+7.05%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E
Revenue Avg	$206M	$222M	$238M
Low	$206M	$221M	$237M
High	$206M	$223M	$238M
EBITDA Avg	$-43M	$-46M	$-49M
Low	$-43M	$-46M	$-49M
High	$-43M	$-46M	$-49M
EBIT Avg	$-49M	$-52M	$-56M
Low	$-49M	$-53M	$-56M
High	$-48M	$-52M	$-56M
Net Income Avg	$-56M	$-55M	$-48M
Low	$-56M	$-55M	$-62M
High	$-56M	$-51M	$-30M
EPS Avg	$-0.89	$-0.84	$-0.72
Low	$-0.89	$-0.87	$-0.97
High	$-0.89	$-0.80	$-0.47
Analysts (Rev / EPS)	4 / 2	4 / 2	2 / 2

Quarterly

Metric	Q2 2026	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028
Revenue Avg	$44M	$48M	$67M	$52M	$48M	$53M	$75M	$57M
Low	$44M	$48M	$67M	$51M	$48M	$52M	$75M	$56M
High	$44M	$48M	$68M	$52M	$49M	$53M	$76M	$57M
EBITDA Avg	$-9M	$-10M	$-14M	$-11M	$-10M	$-11M	$-16M	$-12M
Low	$-9M	$-10M	$-14M	$-11M	$-10M	$-11M	$-16M	$-12M
High	$-9M	$-10M	$-14M	$-11M	$-10M	$-11M	$-15M	$-12M
EBIT Avg	$-10M	$-11M	$-16M	$-12M	$-11M	$-12M	$-18M	$-13M
Low	$-10M	$-11M	$-16M	$-12M	$-11M	$-12M	$-18M	$-13M
High	$-10M	$-11M	$-16M	$-12M	$-11M	$-12M	$-18M	$-13M
Net Income Avg	$-19M	$-16M	$-5M	$-16M	$-17M	$-14M	$-180,859	$-13M
Low	$-19M	$-16M	$-5M	$-16M	$-17M	$-14M	$-182,372	$-13M
High	$-19M	$-16M	$-5M	$-16M	$-16M	$-14M	$-179,078	$-12M
EPS Avg	$-0.30	$-0.25	$-0.07	$-0.24	$-0.26	$-0.22	$-0.00	$-0.19
Low	$-0.30	$-0.25	$-0.07	$-0.24	$-0.26	$-0.22	$-0.00	$-0.20
High	$-0.30	$-0.25	$-0.07	$-0.24	$-0.26	$-0.21	$-0.00	$-0.19
Analysts (Rev / EPS)	3 / 1	3 / 1	2 / 1	1 / 1	2 / 1	2 / 1	1 / 1	1 / 1

Earnings Surprises

Recent Analyst Actions

Jan 7, 2026Stifel Nicolaus

Treace Medical price target lowered to $3 from $5 at Stifel

Target:$3.00

+2.7%from $2.92

Dec 18, 2025Truist Financial

Treace Medical price target lowered to $3 from $4 at Truist

Target:$3.00

+18.3%from $2.54

Nov 10, 2025Truist Financial

Treace Medical price target lowered to $4 from $7 at Truist

Target:$4.00

+3.6%from $3.86

Oct 15, 2025Truist Financial

Treace Medical price target lowered to $7 from $8 at Truist

Target:$7.00

+12.9%from $6.20

Sep 3, 2025Truist Financial

Treace Medical price target raised to $8 from $6.60 at Truist

Target:$8.00

+10.3%from $7.25

Mar 13, 2025Truist Financial

Treace Medical price target lowered to $9.50 from $10 at Truist

Target:$9.50

+19.6%from $7.94

Feb 4, 2025BTIG

Treace Medical upgraded to Buy from Neutral at BTIG

Target:$16.00

+52.2%from $10.51

Dec 31, 2024Lake Street

Treace Medical initiated with a Buy at Lake Street

Target:$14.50

+94.9%from $7.44

May 16, 2024UBS

Treace Medical downgraded to Neutral from Buy at UBS

Target:$6.50

+9.2%from $5.95

Sep 21, 2022BTIG

BTIG Maintains Buy on Treace Medical Concepts, Raises Price Target to $28

Target:$28.00

+16.9%from $23.95

Sep 21, 2022Stifel Nicolaus

Stifel Maintains Buy on Treace Medical Concepts, Raises Price Target to $27

Target:$27.00

+13.1%from $23.87

Jul 18, 2022Stifel Nicolaus

Stifel Maintains Buy on Treace Medical Concepts, Lowers Price Target to $21

Target:$21.00

+28.9%from $16.29

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance